Centronuclear Myopathies Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Tamoxifen Therapy for Myotubular Myopathy
Condition: X Linked Myotubular Myopathy Interventions: Drug: ApoTamox 10mg; Drug: Placebo Sponsors: James Dowling; Canadian Institutes of Health Research (CIHR); Cures Within Reach; The Joshua Frase Foundation USA; Will Cure USA; Mogford Campbell Family Chair Fund; Myotubular Trust Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2021 Category: Research Source Type: clinical trials
Tamoxifen Therapy for Myotubular Myopathy
Condition: X Linked Myotubular Myopathy Interventions: Drug: ApoTamox 10mg; Drug: Placebo Sponsors: James Dowling; Canadian Institutes of Health Research (CIHR); Cures Within Reach; The Joshua Frase Foundation USA; Will Cure USA; Mogford Campbell Family Chair Fund Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2021 Category: Research Source Type: clinical trials
Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies
Condition: Centronuclear Myopathy Intervention: Drug: DYN101 Sponsor: Dynacure Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2021 Category: Research Source Type: clinical trials
